XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Total
Balance at beginning of period at Dec. 31, 2023 $ 308 $ 156,678 $ (123,640) $ (1,912) $ 31,434
Balance at beginning of period (in shares) at Dec. 31, 2023 30,812,329        
Increase (Decrease) in Stockholders' Equity          
Net income     5,846   5,846
Unrealized loss on foreign exchange rate translation       (160) (160)
Dividends     (9,860)   (9,860)
Balance at end of period at Mar. 31, 2024 $ 308 156,678 (127,654) (2,072) 27,260
Balance at end of period (in shares) at Mar. 31, 2024 30,812,329        
Balance at beginning of period at Dec. 31, 2024 $ 310 157,073 (137,619) (2,483) $ 17,281
Balance at beginning of period (in shares) at Dec. 31, 2024 30,983,437       30,983,437
Increase (Decrease) in Stockholders' Equity          
Net income     992   $ 992
Unrealized loss on foreign exchange rate translation       (30) (30)
Stock-based compensation expense   44     44
Issuance of common stock as compensation (in shares) 1,050        
Shares exchanged for taxes on stock-based compensation (in shares) (325)        
Balance at end of period at Mar. 31, 2025 $ 310 $ 157,117 $ (136,627) $ (2,513) $ 18,287
Balance at end of period (in shares) at Mar. 31, 2025 30,984,162       30,984,162